With that challenge in mind, Yang’s team turned to artificial intelligence. Using more than a decade of brain scan data from ...

New international consensus guidelines were developed through a research method, known as a Delphi process, that used a ...

The most effective antipsychotic drug for people with treatment-resistant schizophrenia is clozapine. Yet, across the world, ...

Schizophrenia can be broken down into brain structure and gut health subtypes, which can be used for targeted treatment.

A 33-year-old man with a history of schizophrenia and newly confirmed diagnosis of the chronic condition has been found fit to stand trial on gun and drug charges.

The technology behind the weekly pill is as much mechanical as it is pharmaceutical. Encased in a standard-size capsule is a star-shaped device with six flexible arms. Once the outer shell dissolves ...

A pill taken just once a week, gradually releasing medicine from within the stomach, can greatly simplify the drug schedule faced by schizophrenia patients, researchers reported June 10 in the journal ...

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of exclusivity, has hit a phase 3 setback. Cobenfy as an adjunctive ...

A cortical neuron treated with JRT, a synthetic molecule similar to the psychedelic drug LSD. Drugs like JRT might enable new treatments for conditions such as schizophrenia, without the ...

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.

The Food and Drug Administration has taken a crucial step toward expanding access to the antipsychotic medication clozapine, the only drug approved for treatment-resistant schizophrenia, among the ...

The Food and Drug Administration approved the first new drug in over 30 years to treat schizophrenia in adults. The new drug Cobenfy, formerly known as KarXT, is manufactured by Bristol Myers ...